zeaxanthin and Head-and-Neck-Neoplasms

Smoking negatively affects serum carotenoid levels, and it is a negative prognostic factor for head and neck cancer. In this study, micronutrient levels were examined in 60 smoking and non-smoking head and neck cancer patients. The goal was to determine if oxidation of the carotenoid lycopene would occur to a greater extent in smokers. Subjects were drawn from a prospective cohort study and matched on seven demographic factors. Serum levels of alpha-carotene, zeaxanthin, and 2,6-cyclolycopene-1,5-diol A, an oxidation product of lycopene, were all lower in smokers versus non-smokers (18%, 22%, and 8%, respectively) while beta-carotene, beta-cryptoxanthin, and lutein were about the same in the two groups. Levels of lycopene, gamma-tocopherol, and alpha-tocopherol were higher in smokers, and notably serum alpha-tocopherol was 48% higher in smokers. The majority of vitamin E intake was from supplements. The higher levels of alpha-tocopherol in smokers were interesting in that higher alpha-tocopherol levels have been associated with higher mortality in head and neck cancer. Although this was a pilot investigation, there was no evidence that 2,6-cyclolycopene-1,5-diol A formation was appreciably affected by smoking status, but alpha-tocopherol levels were higher in smokers.

Topics: Adult; Aged; alpha-Tocopherol; beta Carotene; Carotenoids; Case-Control Studies; Cohort Studies; Cryptoxanthins; Diet Records; Female; gamma-Tocopherol; Head and Neck Neoplasms; Humans; Lutein; Lycopene; Male; Micronutrients; Middle Aged; Neoplasms, Squamous Cell; Oxidative Stress; Pilot Projects; Prospective Studies; Smoking; Xanthophylls; Zeaxanthins